Search
Search results
930 results found
Dr Sartori wins 2025 Urology Care Foundation Research Scholar Award
With this prestigious award of the American Urology Association, he will characterize the cell types in the human sacral spinal cord, focusing on the neurons involved in lower urinary tract function. He proposes to investigate which neuron types are evolutionarily conserved between mice and human...
Performing Compound Motor Action Potential Measurement in Zebrafish: A Description of Methodology and a Comparison Between Healthy and ALS-Affected Animals.
Rutkove, Seward, Gaurav Tiwari, and Anjali K Nath. 2025. “Performing Compound Motor Action Potential Measurement in Zebrafish: A Description of Methodology and a Comparison Between Healthy and ALS-Affected Animals.”. Muscle & Nerve 72 (5): 1168-77.
Treatment optimization of subcutaneous infliximab in patients with inflammatory bowel disease.
Gade, Ajay, Alessandra Saraga, Tina Deyhim, Grace Geeganage, Adam S Cheifetz, and Konstantinos Papamichael. 2025. “Treatment Optimization of Subcutaneous Infliximab in Patients With Inflammatory Bowel Disease.”. Expert Review of Gastroenterology & Hepatology.
Flow Cytometry Unit
BD FACSAria II COMS approved facility allows for sterile sorting of fixed and unfixed human, non-human primate, and other animal specimens for HCV and HIV/AIDS research. BD FACS Aria II cell sorter equipped within a Bioprotect IV LE biosafety cabinet operates with 4 solid state lasers: 405nm violet...
Duration of dual antiplatelet therapy (DAPT): a call for personalized medicine.
Tahir, Usman, and Robert W Yeh. 2016. “Duration of Dual Antiplatelet Therapy (DAPT): A Call for Personalized Medicine.”. Journal of Thoracic Disease 8 (10): E1226-E1229.
Individualizing dual antiplatelet therapy duration after percutaneous coronary intervention: from randomized control trials to personalized medicine.
Tahir, Usman A, and Robert W Yeh. 2017. “Individualizing Dual Antiplatelet Therapy Duration After Percutaneous Coronary Intervention: From Randomized Control Trials to Personalized Medicine.”. Expert Review of Cardiovascular Therapy 15 (9): 681-93.
Omics and Cardiometabolic Disease Risk Prediction.
Tahir, Usman A, and Robert E Gerszten. 2020. “Omics and Cardiometabolic Disease Risk Prediction.”. Annual Review of Medicine 71: 163-75.
Metabolomic Markers of Southern Dietary Patterns in the Jackson Heart Study.
Rebholz, Casey M, Yan Gao, Sameera Talegawkar, Katherine L Tucker, Lisandro D Colantonio, Paul Muntner, Debby Ngo, et al. 2021. “Metabolomic Markers of Southern Dietary Patterns in the Jackson Heart Study.”. Molecular Nutrition & Food Research 65 (8): e2000796.
Metabolomic Analysis of Coronary Heart Disease in an African American Cohort From the Jackson Heart Study.
Cruz, Daniel E, Usman A Tahir, Jie Hu, Debby Ngo, Zsu-Zsu Chen, Jeremy M Robbins, Daniel Katz, et al. 2022. “Metabolomic Analysis of Coronary Heart Disease in an African American Cohort From the Jackson Heart Study.”. JAMA Cardiology 7 (2): 184-94.